Transcripts Neurogene Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-20 pm EDT			5-day change	1st Jan Change
26.95 ^USD	+0.26%		-14.55%	+30.83%

May. 12	Neurogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
May. 12	Neurogene Inc Highlights Data Supporting Therapeutic Rationale For ICV Delivery Method In CNS-Targeted Gene Therapy	CI

Nov. 12	Neurogene Inc. Presents at Stifel 2025 Healthcare Conference, Nov-12-2025 04:40 PM
23-07-18	Neoleukin Therapeutics, Inc., Neurogene Inc. - M&A Call
22-08-09	Neoleukin Therapeutics, Inc., Q2 2022 Earnings Call, Aug 09, 2022
22-05-11	Neoleukin Therapeutics, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 01:20 PM
22-03-01	Neoleukin Therapeutics, Inc., Q4 2021 Earnings Call, Mar 01, 2022
21-05-13	Neoleukin Therapeutics, Inc. - Shareholder/Analyst Call
21-05-12	Neoleukin Therapeutics, Inc. Presents at BofA Securities 2021 Virtual Health Care Conference, May-12-2021 10:15 AM
21-03-25	Neoleukin Therapeutics, Inc., 2020 Earnings Call, Mar 25, 2021
21-01-14	Neoleukin Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-14-2021 01:30 PM
20-08-12	Neoleukin Therapeutics, Inc., Q2 2020 Earnings Call, Aug 12, 2020
20-06-23	Neoleukin Therapeutics, Inc. - Special Call
20-05-14	Neoleukin Therapeutics, Inc. Presents at BofA Securities 2020 Health Care Conference, May-14-2020 02:20 PM
20-05-05	Neoleukin Therapeutics, Inc. - Shareholder/Analyst Call
20-03-12	Neoleukin Therapeutics, Inc., 2019 Earnings Call, Mar 12, 2020
19-08-06	Aquinox Pharmaceuticals, Inc., Neoleukin Therapeutics, Inc - M&A Call